Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eolas Therapeutics Inc.

www.eolastherapeutics.com

Latest From Eolas Therapeutics Inc.

Deal Watch: Allergan Diversifies With Deals For Migraine Therapies, Ophthalmologic Device

AMAG adds to its commercial and technological capabilities with a buyout of Cord Blood Registry. Meanwhile, ramifications of the GSK/Novartis asset swap from March continue, with GSK divesting a pair of vaccines to Pfizer, while Novartis acquires Australian biotech Spinifex.

BioPharmaceutical Deals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Eolas Therapeutics Inc.
  • Senior Management
  • Albert Man, PhD, CEO
  • Contact Info
  • Eolas Therapeutics Inc.
    6965 El Camino Real
    Ste. 102-125
    Carlsbad, CA 92009
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register